Xinglian Biotechnology

BiotechnologyAngelTianjin, Chinaconjustar.com

Latest round

Angel

Last raised

Feb 2023

Total raised

$15M

Investors

4

About Xinglian Biotechnology

Based in Tianjin, China, and founded in 2022, Xinglian Biotechnology operates as a biotechnology developer, specializing in the development of protein-coupled drugs. In 2024, it established the Zhuhai Research Center. Xinglian Biotechnology focuses on the research and development of protein-coupled drugs and has established pipelines through a combination of external introduction and in-house R&D. The company's product pipeline can be used to treat tumors. The company generates revenue by developing protein-coupled drugs. The company will use the funds to develop clinical trials of core products and new products to accelerate the clinical transformation of XDC drugs.

Who invested in Xinglian Biotechnology

4 investors across 2 rounds

See all investors in Xinglian Biotechnology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Feb 21, 2023

    Amount

    $7.9M

    Investors

    Locked

  2. Seed

    Mar 8, 2022

    Amount

    $7.2M

    Investors

    Locked

Questions about Xinglian Biotechnology

Who invested in Xinglian Biotechnology?

Xinglian Biotechnology has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Xinglian Biotechnology raised?

Xinglian Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Xinglian Biotechnology last raise money?

Xinglian Biotechnology's most recent round on record is a Angel, in Feb 2023.

What does Xinglian Biotechnology do?

Based in Tianjin, China, and founded in 2022, Xinglian Biotechnology operates as a biotechnology developer, specializing in the development of protein-coupled drugs.

Where is Xinglian Biotechnology headquartered?

Xinglian Biotechnology is headquartered in Tianjin, China.

Which VCs invest in companies like Xinglian Biotechnology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Xinglian Biotechnology's stage. Their profiles are linked below.

Raising like Xinglian Biotechnology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.